PROBUS SURGERY
TREGONY ROAD, PROBUS, TRURO
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 17 | 19 | 89.5% | |
| HF 4 | 2011 | 19 | 21 | 90.5% | |
| HF 4 | 2012 | 23 | 26 | 88.5% | |
| HF 4 | 2013 | 28 | 30 | 93.3% | |
| HF004 | 2014 | 15 | 15 | 100.0% | |
| HF004 | 2015 | 14 | 14 | 100.0% | |
| HF004 | 2016 | 16 | 17 | 94.1% | |
| HF004 | 2017 | 24 | 24 | 100.0% | |
| HF004 | 2018 | 26 | 26 | 100.0% | |
| HF004 | 2020 | 27 | 27 | 100.0% | |
| HF006 | 2021 | 48 | 58 | 82.8% | |
| HF006 | 2022 | 52 | 53 | 98.1% | |
| HF006 | 2023 | 53 | 56 | 94.6% |
